A Mycobacterium tuberculosis sigma factor network responds to cell-envelope damage by the promising anti-mycobacterial thioridazine.
BACKGROUND
Novel therapeutics are urgently needed to control tuberculosis (TB). Thioridazine (THZ) is a candidate for the therapy of multidrug and extensively drug-resistant TB.


RESULTS
We studied the impact of THZ on Mycobacterium tuberculosis (Mtb) by analyzing gene expression profiles after treatment at the minimal inhibitory (1x MIC) or highly inhibitory (4x MIC) concentrations between 1-6 hours. THZ modulated the expression of genes encoding membrane proteins, efflux pumps, oxido-reductases and enzymes involved in fatty acid metabolism and aerobic respiration. The Rv3160c-Rv3161c operon, a multi-drug transporter and the Rv3614c/3615c/3616c regulon, were highly induced in response to THZ. A significantly high number of Mtb genes co-expressed with sigma(B) (the sigma(B) regulon) was turned on by THZ treatment. sigma(B) has recently been shown to protect Mtb from envelope-damage. We hypothesized that THZ damages the Mtb cell-envelope, turning on the expression of the sigma(B) regulon. Consistent with this hypothesis, we present electron-microscopy data which shows that THZ modulates cell-envelope integrity. Moreover, the Mtb mutants in sigma(H) and sigma(E), two alternate stress response sigma factors that induce the expression of sigma(B), exhibited higher sensitivity to THZ, indicating that the presence and expression of sigma(B) allows Mtb to resist the impact of THZ. Conditional induction of sigma(B) levels increased the survival of Mtb in the presence of THZ.


CONCLUSIONS
THZ targets different pathways and can thus be used as a multi-target inhibitor itself as well as provide strategies for multi-target drug development for combination chemotherapy. Our results show that the Mtb sigma factor network comprising of sigma(H), sigma(E) and sigma(B) plays a crucial role in protecting the pathogen against cell-envelope damage.
Dutta
Noton K
NK
Division of Bacteriology and Parasitology, Tulane National Primate Research Center, Covington, Louisiana, United States of America.
Mehra
Smriti
S
Kaushal
Deepak
D
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D002473:Cell Wall / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D020869:Gene Expression Profiling; D005786:Gene Expression Regulation / Q000187:drug effects; D005798:Genes, Bacterial / Q000187:drug effects; D007700:Kinetics; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000235:genetics* / Q000648:ultrastructure; D012808:Sigma Factor / Q000235:genetics*; D013881:Thioridazine / Q000494:pharmacology* / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D012808:Sigma Factor; D013881:Thioridazine
Tuberculosis (Edinb). 2004;84(3-4):263-74
15207496
FEMS Microbiol Lett. 1992 Oct 1;76(1-2):73-6
1427006
Curr Drug Targets. 2008 Sep;9(9):816-9
18781927
Infect Immun. 2000 Oct;68(10):5575-80
10992456
Bioorg Med Chem Lett. 2007 Mar 1;17(5):1346-8
17188865
Infect Immun. 2003 Dec;71(12):7170-2
14638810
Metab Eng. 2002 Apr;4(2):182-92
12009797
Mol Microbiol. 1995 Jan;15(2):355-66
7746156
J Exp Med. 2003 Sep 1;198(5):693-704
12953091
Microb Pathog. 2001 May;30(5):271-8
11373121
Microbiology (Reading). 2007 Apr;153(Pt 4):1229-1242
17379732
Mol Microbiol. 2001 Jul;41(2):423-37
11489128
Int J Antimicrob Agents. 2001 Mar;17(3):225-8
11282269
J Bacteriol. 1992 Jun;174(12):3843-9
1597408
Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12833-8
10536008
J Immunol. 1999 Jun 1;162(11):6740-6
10352293
Antimicrob Agents Chemother. 2005 Nov;49(11):4778-80
16251329
J Antimicrob Chemother. 2007 Jun;59(6):1271-9
17403708
Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):8330-5
12060776
Infect Immun. 1999 Sep;67(9):4931-4
10456953
J Biol Chem. 2006 Apr 28;281(17):11456-63
16469750
Mol Microbiol. 2010 Feb;75(3):538-42
20025668
J Biol Chem. 2004 Sep 17;279(38):40174-84
15247240
J Bacteriol. 2008 Jan;190(2):699-707
17993538
Bull World Health Organ. 2007 May;85(5):327
17639210
Mol Microbiol. 2002 Jul;45(2):365-74
12123450
Tuber Lung Dis. 1997;78(3-4):175-83
9713650
Mol Microbiol. 2010 Feb;75(3):592-606
20025669
Cell Host Microbe. 2007 Nov 15;2(5):352-64
18005756
Antimicrob Agents Chemother. 2008 Oct;52(10):3604-11
18694955
J Bacteriol. 2004 Feb;186(4):895-902
14761983
Antimicrob Agents Chemother. 2004 Jul;48(7):2415-23
15215089
J Bacteriol. 2009 Jun;191(12):3965-80
19376862
Proc Natl Acad Sci U S A. 2005 Mar 22;102(12):4548-53
15767566
Int J Antimicrob Agents. 2008 Mar;31(3):198-208
18180147
Antimicrob Agents Chemother. 2003 Mar;47(3):917-22
12604522
J Antimicrob Chemother. 1996 Jan;37(1):196-7
8647767
Antimicrob Agents Chemother. 2003 Sep;47(9):2903-13
12936993
J Antimicrob Chemother. 2008 Dec;62(6):1215-21
18836185
In Vivo. 2007 Sep-Oct;21(5):771-5
18019410
J Biol Chem. 2006 Feb 17;281(7):3866-75
16354661
J Bacteriol. 2005 Jun;187(12):4173-86
15937179
Int J Antimicrob Agents. 2007 Oct;30(4):336-40
17644321
Microbiology (Reading). 2009 Apr;155(Pt 4):1093-1102
19332811
Int J Antimicrob Agents. 2007 Mar;29(3):338-40
17239569
J Antimicrob Chemother. 2007 Jun;59(6):1237-46
17218448
Nature. 2008 Aug 7;454(7205):717-21
18685700
J Bacteriol. 2006 Jan;188(1):150-9
16352831
J Bacteriol. 2008 Apr;190(8):2981-6
18296525
Nat Rev Microbiol. 2008 Jan;6(1):41-52
18079742
J Bacteriol. 2009 Sep;191(18):5628-33
19592585
Mol Microbiol. 1998 Jun;28(6):1059-66
9680198
J Med Microbiol. 2009 Dec;58(Pt 12):1667-1668
19696152
Cell Microbiol. 2003 Sep;5(9):637-48
12925133
Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11554-9
10500215